Press Release: Datopotamab-Deruxtecan Demonstrates Survival Benefit in First-Line Metastatic Triple-Negative Breast Cancer

Datopotamab-Deruxtecan

OncoDaily Party Berlin 2025

OncoDaily Party Berlin 2025

2025 Nobel Prize in Physiology or Medicine: Peripheral Immune Tolerance, FOXP3, and the Future of Immunotherapy

2025 Nobel Prize in Physiology or Medicine: Peripheral Immune Tolerance, FOXP3, and the Future of Immunotherapy

Nicholas DeVito: The Importance and Urgency of Robust NIH and NCI Funding

Nicholas DeVito,

Amol Akhade: New Molecules to Look Forward to in GI Cancers at ESMO 2025 

Amol Akhade

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Yelak Biru: The Age of the Tech-Empowered Patient Partnership

Yelak Biru

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology

OncoCalendar

« All Events

  • This event has passed.

Refresher course for diagnosis and management of early-stage lung cancer by ESO

Mar 20 • 6:00 PM - Mar 22 • 12:00 PM
Refresher course for diagnosis and management of early-stage lung cancer by ESO

Refresher course for diagnosis and management of early-stage lung cancer by ESO will be held at Belgrade, Serbia from March 20-22, 2025.

This course is designed to provide a comprehensive understanding of the latest diagnostic and therapeutic approaches in the diagnosis and management of early-stage lung cancer. The primary goal is to enhance multidisciplinary collaboration between respiratory physicians, thoracic surgeons, and oncologists to ensure accurate diagnosis, staging, and the development of individualized treatment plans. Emphasizing the latest advancements in imaging techniques, biopsy procedures, molecular testing, oncology, and surgical management, the course will equip participants with the essential skills to accurately assess and treat early-stage lung cancer. This will ensure that patients receive timely, targeted, and effective interventions.

The course aims to deepen participants’ knowledge of both surgical and non-surgical treatment options. This includes minimally invasive techniques, stereotactic body radiotherapy (SBRT), and the role of adjuvant therapies. By incorporating case-based learning and evidence-based guidelines, the course will help foster a patient-centered approach to care. This approach emphasizes the importance of shared decision-making and long-term follow-up for improving patient outcomes. The ultimate goal is to empower physicians to optimize treatment outcomes, reduce recurrence rates, and enhance patient survival and quality of life.

Details

Start:
Mar 20 • 6:00 PM
End:
Mar 22 • 12:00 PM
Website:
https://www.eso.net/en/what-we-do/future-events/refresher-course-on-early-lung-cancer/3-6592-0-?utm_source=social&utm_medium=banner&utm_campaign=RefresherLung

Organizer

European School of Oncology
Phone
+41 91 820 09 50
Email
eso@eso.net
View Organizer Website

Venue

Belgrade
Belgrade, Serbia + Google Map